Loading...

Zvavahera Chirenje, MD

Title(s)Academic Coordinator III, Ob/Gyn, Reproductive Sciences
SchoolSchool of Medicine
Phone263-470-4890
vCardDownload vCard

    Collapse Research 
    Collapse Research Activities and Funding
    The Bixby Center for Global Reproductive Health - Annual Research Day Conference
    NIH/NIAID R13AI132016Aug 1, 2017 - Jul 31, 2018
    Role: Principal Investigator
    UZCHS CTU
    NIH/NIAID UM1AI069436Mar 1, 2007 - Nov 30, 2020
    Role: Principal Investigator
    UZ-UCSF Clinical Trials Unit
    NIH/NIAID U01AI069436Mar 1, 2007 - Nov 30, 2013
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials
    Collapse Global Health

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Reddy K, Kelly C, Brown ER, Jeenarain N, Naidoo L, Siva S, Bekker LG, Nair G, Makanani B, Chinula L, Mgodi N, Chirenje Z, Kiweewa FM, Marrazzo J, Bunge K, Soto-Torres L, Piper J, Baeten JM, Palanee-Phillips T. Use of the dapivirine vaginal ring and effect on cervical cytology abnormalities. AIDS. 2019 Nov 19. PMID: 31764068.
      View in: PubMed
    2. Matubu TA, Hillier SL, Meyn LA, Stoner KA, Mhlanga F, Mbizvo M, Maramba A, Chirenje ZM, Achilles SL. Depot medroxyprogesterone acetate and norethisterone enanthate differentially impact T-cell responses and expression of immunosuppressive markers. Am J Reprod Immunol. 2019 Nov 14; e13210. PMID: 31729087.
      View in: PubMed
    3. Browne EN, Montgomery ET, Mansfield C, Boeri M, Mange B, Beksinska M, Schwartz JL, Clark MR, Doncel GF, Smit J, Chirenje ZM, van der Straten A. Efficacy is Not Everything: Eliciting Women's Preferences for a Vaginal HIV Prevention Product Using a Discrete-Choice Experiment. AIDS Behav. 2019 Nov 06. PMID: 31696371.
      View in: PubMed
    4. Gwanzura C, Muyotcha AF, Magwali T, Chirenje ZM, Madziyire MG. Giant mucinous cystadenoma: a case report. J Med Case Rep. 2019 Jun 14; 13(1):181. PMID: 31196215.
      View in: PubMed
    5. Ziki EM, Chirenje ZM, Madziyire MG. A case of twin reversed arterial perfusion (TRAP) sequence managed conservatively. Pan Afr Med J. 2019; 32:54. PMID: 31143359.
      View in: PubMed
    6. Stephen S, Muzhizhizhi D, Dhibi N, Chidemo T, Samaneka W, Matubu TA, Hakim JG, Chirenje ZM. Validation of the GenoType® MTBDRplus Ver 2.0 assay for detection of rifampicin and isoniazid resistance in Mycobacterium tuberculosis complex isolates at UZCHS-CTRC TB research laboratory. Int J Mycobacteriol. 2019 Jan-Mar; 8(1):83-88. PMID: 30860184.
      View in: PubMed
    7. Chinyowa S, Palefsky JM, Chirenje ZM, Makunike-Mutasa R, Munjoma M, Muguti GI. Anal human papillomavirus infection in HIV-positive men and women at two opportunistic infections clinics in Harare, Zimbabwe. BMC Public Health. 2018 Nov 14; 18(1):1260. PMID: 30428859.
      View in: PubMed
    8. Majangara R, Chirenje ZM, Gidiri MF. The association of puerperal sepsis with HIV infection at two tertiary hospitals in Zimbabwe. Int J Gynaecol Obstet. 2019 Jan; 144(1):67-72. PMID: 30343490.
      View in: PubMed
    9. Achilles SL, Austin MN, Meyn LA, Mhlanga F, Chirenje ZM, Hillier SL. Impact of contraceptive initiation on vaginal microbiota. Am J Obstet Gynecol. 2018 06; 218(6):622.e1-622.e10. PMID: 29505773.
      View in: PubMed
    10. Majangara R, Gidiri MF, Chirenje ZM. Microbiology and clinical outcomes of puerperal sepsis: a prospective cohort study. J Obstet Gynaecol. 2018 Jul; 38(5):635-641. PMID: 29447024.
      View in: PubMed
    11. Achilles SL, Mhlanga FG, Musara P, Poloyac SM, Chirenje ZM, Hillier SL. Misreporting of contraceptive hormone use in clinical research participants. Contraception. 2018 04; 97(4):346-353. PMID: 28966052.
      View in: PubMed
    12. Livant E, Heaps A, Kelly C, Maharaj R, Samsunder N, Nhlangulela L, Karugaba P, Panchia R, Marrazzo J, Chirenje ZM, Parikh UM. The fourth generation AlereTM HIV Combo rapid test improves detection of acute infection in MTN-003 (VOICE) samples. J Clin Virol. 2017 09; 94:15-21. PMID: 28710996.
      View in: PubMed
    13. Dube Mandishora RS, Christiansen IK, Chin'ombe N, Duri K, Ngara B, Rounge TB, Meisal R, Ambur OH, Palefsky JM, Stray-Pedersen B, Chirenje ZM. Genotypic diversity of anogenital human papillomavirus in women attending cervical cancer screening in Harare, Zimbabwe. J Med Virol. 2017 09; 89(9):1671-1677. PMID: 28390142.
      View in: PubMed
    14. Chirenje ZM, Gundacker HM, Richardson B, Rabe L, Gaffoor Z, Nair GL, Mirembe BG, Piper JM, Hillier S, Marrazzo J. Risk Factors for Incidence of Sexually Transmitted Infections Among Women in a Human Immunodeficiency Virus Chemoprevention Trial: VOICE (MTN-003). Sex Transm Dis. 2017 03; 44(3):135-140. PMID: 28178109.
      View in: PubMed
    15. Akello CA, Bunge KE, Nakabiito C, Mirembe BG, Fowler MG, Mishra A, Marrazzo J, Chirenje ZM, Celum C, Balkus JE. Contraceptive Use and Pregnancy Incidence Among Women Participating in an HIV Prevention Trial. J Womens Health (Larchmt). 2017 06; 26(6):670-676. PMID: 28437215.
      View in: PubMed
    16. Samaneka WP, Mandozana G, Tinago W, Nhando N, Mgodi NM, Bwakura-Dangarembizi MF, Munjoma MW, Gomo ZA, Chirenje ZM, Hakim JG. Adult Hematology and Clinical Chemistry Laboratory Reference Ranges in a Zimbabwean Population. PLoS One. 2016; 11(11):e0165821. PMID: 27812172.
      View in: PubMed
    17. Mensch BS, Brown ER, Liu K, Marrazzo J, Chirenje ZM, Gomez K, Piper J, Patterson K, van der Straten A. Reporting of Adherence in the VOICE Trial: Did Disclosure of Product Nonuse Increase at the Termination Visit? AIDS Behav. 2016 11; 20(11):2654-2661. PMID: 26906023.
      View in: PubMed
    18. Balkus JE, Brown E, Palanee T, Nair G, Gafoor Z, Zhang J, Richardson BA, Chirenje ZM, Marrazzo JM, Baeten JM. An Empiric HIV Risk Scoring Tool to Predict HIV-1 Acquisition in African Women. J Acquir Immune Defic Syndr. 2016 07 01; 72(3):333-43. PMID: 26918545.
      View in: PubMed
    19. Balkus JE, Brown ER, Hillier SL, Coletti A, Ramjee G, Mgodi N, Makanani B, Reid C, Martinson F, Soto-Torres L, Abdool Karim SS, Chirenje ZM. Corrigendum to "oral and injectable contraceptive use and HIV acquisition risk among women in four African countries: a secondary analysis of data from a microbicide trial" [Contraception 2016; 93 (1): 25-31]. Contraception. 2016 Jul; 94(1):95. PMID: 27085419.
      View in: PubMed
    20. Baeten JM, Palanee-Phillips T, Brown ER, Schwartz K, Soto-Torres LE, Govender V, Mgodi NM, Matovu Kiweewa F, Nair G, Mhlanga F, Siva S, Bekker LG, Jeenarain N, Gaffoor Z, Martinson F, Makanani B, Pather A, Naidoo L, Husnik M, Richardson BA, Parikh UM, Mellors JW, Marzinke MA, Hendrix CW, van der Straten A, Ramjee G, Chirenje ZM, Nakabiito C, Taha TE, Jones J, Mayo A, Scheckter R, Berthiaume J, Livant E, Jacobson C, Ndase P, White R, Patterson K, Germuga D, Galaska B, Bunge K, Singh D, Szydlo DW, Montgomery ET, Mensch BS, Torjesen K, Grossman CI, Chakhtoura N, Nel A, Rosenberg Z, McGowan I, Hillier S. Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in Women. N Engl J Med. 2016 12 01; 375(22):2121-2132. PMID: 26900902.
      View in: PubMed
    21. Balkus JE, Brown ER, Hillier SL, Coletti A, Ramjee G, Mgodi N, Makanani B, Reid C, Martinson F, Soto-Torres L, Abdool Karim SS, Chirenje ZM. Oral and injectable contraceptive use and HIV acquisition risk among women in four African countries: a secondary analysis of data from a microbicide trial. Contraception. 2016 Jan; 93(1):25-31. PMID: 26519646.
      View in: PubMed
    22. Balkus JE, Nair G, Montgomery ET, Mishra A, Palanee-Phillips T, Ramjee G, Panchia R, Selepe P, Richardson BA, Chirenje ZM, Marrazzo JM. Age-Disparate Partnerships and Risk of HIV-1 Acquisition Among South African Women Participating in the VOICE Trial. J Acquir Immune Defic Syndr. 2015 Oct 01; 70(2):212-7. PMID: 26049280.
      View in: PubMed
    23. Gomani P, Matubu AT, Mujuru HA, Munjoma MW, Tinago W, Mandozana G, Hakim JG, Gomo ZA, Chirenje ZM. Hematological and biochemical laboratory reference intervals for Zimbabwean adolescents. Clin Lab. 2015; 61(1-2):101-11. PMID: 25807644.
      View in: PubMed
    24. Dezzutti CS, Richardson BA, Marrazzo JM, Tugetman J, Ramjee G, Taha T, Chirenje ZM, Abdool Karim SS, Hillier SL, Herold BC. Mucosal Escherichia coli bactericidal activity and immune mediators are associated with HIV-1 seroconversion in women participating in the HPTN 035 trial. J Infect Dis. 2012 Dec 15; 206(12):1931-5. PMID: 22966121.
      View in: PubMed
    25. Chirenje ZM, Mâsse BR, Maslankowski LA, Ramjee G, Coletti AS, Tembo TN, Magure TM, Soto-Torres L, Kelly C, Hillier S, Karim A. Utility of colposcopy in a phase 2 portion of a microbicide clinical trial of BufferGel and 0.5% PRO 2000 Gel. J Int AIDS Soc. 2012 Aug 27; 15(2):17376. PMID: 22944480.
      View in: PubMed
    26. Abdool Karim SS, Richardson BA, Ramjee G, Hoffman IF, Chirenje ZM, Taha T, Kapina M, Maslankowski L, Coletti A, Profy A, Moench TR, Piwowar-Manning E, Mâsse B, Hillier SL, Soto-Torres L. Safety and effectiveness of BufferGel and 0.5% PRO2000 gel for the prevention of HIV infection in women. AIDS. 2011 Apr 24; 25(7):957-66. PMID: 21330907.
      View in: PubMed
    27. Israel-Ballard KA, Maternowska MC, Abrams BF, Morrison P, Chitibura L, Chipato T, Chirenje ZM, Padian NS, Chantry CJ. Acceptability of heat treating breast milk to prevent mother-to-child transmission of human immunodeficiency virus in Zimbabwe: a qualitative study. J Hum Lact. 2006 Feb; 22(1):48-60. PMID: 16467287.
      View in: PubMed
    28. Njoroge B, Chirenje ZM, Pandey B, Mirembe F, Joshi S, Low-Beer N, Maslankowski LA. The CONRAD/WHO Update 2000 colposcopy manual: how well is it working? J Acquir Immune Defic Syndr. 2004 Oct; 37 Suppl 3:S150-1. PMID: 16419263.
      View in: PubMed